Financials

  • Market Capitalization 32.86 M
  • Employee 162
  • Founded 2015
  • CEO N/A
  • Website www.gossamerbio.com
  • Headquarter Delaware, United States
  • FIGI BBG00MVWLLM2
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-4.13
Price to sales ratio
14.62

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
4447
RADX
Radiopharm Theranostics Limited American Depositary Shares
4.33 USD-0.92%+2.85%+2.85%+1.88%34.13 M USD
4452
LSTA
Lisata Therapeutics, Inc. - Common Stock
3.70 USD+13.15%+11.11%+5.11%+42.86%33.69 M USD
4461
BCTX
BriaCell Therapeutics Corp. - Common Shares
3.75 USD-4.82%+5.04%+31.12%+89.39%32.62 M USD
4464
LITS
Lite Strategy, Inc. - Common Stock
0.95 USD-5.94%-3.06%+21.79%-68.12%32.32 M USD

Frequently asked questions about Gossamer Bio, Inc. - Common Stock

What is the Gossamer Bio, Inc. - Common Stock stock price today?

The current price of Gossamer Bio, Inc. - Common Stock (GOSS) is 0.14. Over the past 24 hours, the stock has changed by -17.65%. Follow the GOSS chart for real-time price dynamics.

What is the stock ticker of Gossamer Bio, Inc. - Common Stock?

Gossamer Bio, Inc. - Common Stock trades under the ticker GOSS. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Gossamer Bio, Inc. - Common Stock stock going up?

GOSS has changed by -26.32% over the last week, -17.65% over the last month, and -90.91% over the last year. Review the chart to see whether the current move is part of a broader trend.

What was Gossamer Bio, Inc. - Common Stock net income for the last quarter?

Gossamer Bio, Inc. - Common Stock reported net income of -46.66 M for the last quarter. The previous quarter showed -47.24 M, which means net income changed by +1.22%.

How many employees does Gossamer Bio, Inc. - Common Stock have?

As of the latest available data, Gossamer Bio, Inc. - Common Stock has 162 employees. Workforce size can provide additional context about the company's scale and operations.

What is Gossamer Bio, Inc. - Common Stock EBITDA?

Gossamer Bio, Inc. - Common Stock EBITDA is -44.86 M, and its EBITDA margin is -264.59%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Gossamer Bio, Inc. - Common Stock stock?

You can buy Gossamer Bio, Inc. - Common Stock (GOSS) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Gossamer Bio, Inc. - Common Stock stock?

Investing in Gossamer Bio, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the GOSS chart and related analysis on metatrader.com as part of your research.

News